CLASS IIDrug recall · Reported 22 Feb 2023 · FDA Enforcement Report
Kytril 350MCG IN NS Syringe, antimetic recalled
Sentara Infusion Services is recalling Kytril 350MCG IN NS Syringe, antimetic, distributed nationwide in the US. The recall was initiated on 27 Dec 2022 and the FDA has classified it as Class II.
Check your package
Lot, batch or date codesBeyond Use Date: December 29, 2022
Quantity recalled14 syringes
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Lack of sterility assurance
A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.
Product as listed by the FDA
KYTRIL 350MCG IN 3.5ML NS SYRINGE, antimetic, Rx Only, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.